.png)
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
BLOG
Read on
%201.png)
Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Boston, MA: Process & Analytical Development and Manufacturing Facility
The launch of our Process & Analytical Development and Manufacturing Facility marks a strategic resurgence in the Boston area, as we consolidate and...
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
On-Demand Webinar: High-Throughput Process & Analytical Platforms to Accelerate Gene Therapy Scale-Up
For revolutionary gene therapies to reach their full therapeutic potential, high throughput process development workflows are needed to keep pace...
Overcoming Obstacles in Gene Therapy Manufacturing
The gene therapy and viral vector space has yet to achieve the level of standardization that typifies established modalities, such as monoclonal...
Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies
Resilience has entered into a strategic collaboration with Labcorp to establish a joint customer service offering that provides an end-to-end...
Master Cell Banks: Laying the Foundation to Final Product Success
Consider our top 5 FAQs when it comes to MCBs Master cell banks (MCBs) are a critical starting material that lay the foundation for the scale-up and...
